Literature DB >> 34082803

Maternal and neonatal risk factors for neonatal respiratory distress syndrome in term neonates in Cyprus: a prospective case-control study.

Paraskevi Stylianou-Riga1,2,3, Theodora Boutsikou4, Panayiotis Kouis5, Paraskevi Kinni5, Marina Krokou5, Andriani Ioannou5, Tania Siahanidou6, Zoi Iliodromiti4, Thalia Papadouri7, Panayiotis K Yiallouros5, Nicoletta Iacovidou4.   

Abstract

BACKGROUND: Neonatal respiratory distress syndrome (NRDS) is strongly associated with premature birth, but it can also affect term neonates. Unlike the extent of research in preterm neonates, risk factors associated with incidence and severity of NRDS in term neonates are not well studied. In this study, we examined the association of maternal and neonatal risk factors with the incidence and severity of NRDS in term neonates admitted to Neonatal Intensive Care Unit (NICU) in Cyprus.
METHODS: In a prospective, case-control design we recruited term neonates with NRDS and non-NRDS admitted to the NICU of Archbishop Makarios III hospital, the only neonatal tertiary centre in Cyprus, between April 2017-October 2018. Clinical data were obtained from patients' files. We used univariate and multivariate logistic and linear regression models to analyse binary and continuous outcomes respectively.
RESULTS: During the 18-month study period, 134 term neonates admitted to NICU were recruited, 55 (41%) with NRDS diagnosis and 79 with non-NRDS as controls. In multivariate adjusted analysis, male gender (OR: 4.35, 95% CI: 1.03-18.39, p = 0.045) and elective caesarean section (OR: 11.92, 95% CI: 1.80-78.95, p = 0.01) were identified as independent predictors of NRDS. Among neonates with NRDS, early-onset infection tended to be associated with increased administration of surfactant (β:0.75, 95% CI: - 0.02-1.52, p = 0.055). Incidence of pulmonary hypertension or systemic hypotension were associated with longer duration of parenteral nutrition (pulmonary hypertension: 11Vs 5 days, p < 0.001, systemic hypotension: 7 Vs 4 days, p = 0.01) and higher rate of blood transfusion (pulmonary hypertension: 100% Vs 67%, p = 0.045, systemic hypotension: 85% Vs 55%, p = 0.013).
CONCLUSIONS: This study highlights the role of elective caesarean section and male gender as independent risk factors for NRDS in term neonates. Certain therapeutic interventions are associated with complications during the course of disease. These findings can inform the development of evidence-based recommendations for improved perinatal care.

Entities:  

Keywords:  Caesarean section; Maternal risk factors; Neonatal respiratory distress syndrome; Neonatal risk factors

Year:  2021        PMID: 34082803     DOI: 10.1186/s13052-021-01086-5

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN: 1720-8424            Impact factor:   2.638


  51 in total

Review 1.  Neonatal respiratory morbidity following elective caesarean section in term infants. A 5-year retrospective study and a review of the literature.

Authors:  A van den Berg; R M van Elburg; H P van Geijn; W P Fetter
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-09       Impact factor: 2.435

2.  A comparison of clinical variables that predict adverse outcome in term infants with severe respiratory failure randomised to a policy of extracorporeal membrane oxygenation or to conventional neonatal intensive care.

Authors:  Charlotte C Bennett; Ann Johnson; David J Field
Journal:  J Perinat Med       Date:  2002       Impact factor: 1.901

Review 3.  Elective cesarean section: its impact on neonatal respiratory outcome.

Authors:  Ashwin Ramachandrappa; Lucky Jain
Journal:  Clin Perinatol       Date:  2008-06       Impact factor: 3.430

Review 4.  Respiratory distress in the newborn.

Authors:  Suzanne Reuter; Chuanpit Moser; Michelle Baack
Journal:  Pediatr Rev       Date:  2014-10

5.  Measurement of translational motion by pulse-gradient spin-echo nuclear magnetic resonance.

Authors:  R L Haner; T Schleich
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

6.  Infant Outcomes After Elective Early-Term Delivery Compared With Expectant Management.

Authors:  Jason L Salemi; Elizabeth B Pathak; Hamisu M Salihu
Journal:  Obstet Gynecol       Date:  2016-04       Impact factor: 7.661

7.  Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study.

Authors:  Anne Kirkeby Hansen; Kirsten Wisborg; Niels Uldbjerg; Tine Brink Henriksen
Journal:  BMJ       Date:  2007-12-11

8.  Severe respiratory disorders in term neonates.

Authors:  Jean-Bernard Gouyon; C Ribakovsky; C Ferdynus; C Quantin; P Sagot; B Gouyon
Journal:  Paediatr Perinat Epidemiol       Date:  2008-01       Impact factor: 3.980

9.  High-risk Factors of Respiratory Distress Syndrome in Term Neonates: A Retrospective Case-control Study.

Authors:  Jing Liu; Na Yang; Ying Liu
Journal:  Balkan Med J       Date:  2014-03-01       Impact factor: 2.021

10.  Short term evaluation of respiratory effort by premature infants supported with bubble nasal continuous airway pressure using Seattle-PAP and a standard bubble device.

Authors:  Stephen E Welty; Craig G Rusin; Larissa I Stanberry; George T Mandy; Alfred L Gest; Jeremy M Ford; Carl H Backes; C Peter Richardson; Christopher R Howard; Thomas N Hansen; Charles V Smith
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

View more
  2 in total

1.  Efficacy and safety of nasal intermittent positive pressure ventilation and nasal continuous positive airway pressure ventilation in neonatal respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Hua Liu; Haiping Feng; Yao Zhang; Li Zhang
Journal:  Transl Pediatr       Date:  2022-07

2.  Evaluation of the neonatal sequential organ failure assessment and mortality risk in neonates with respiratory distress syndrome: A retrospective cohort study.

Authors:  Shanshan Shi; Jie Guo; Minqiang Fu; Lihua Liao; Jiabin Tu; Jialing Xiong; Quanwang Liao; Weihua Chen; Kaihong Chen; Ying Liao
Journal:  Front Pediatr       Date:  2022-07-22       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.